Complications of treatments of carcinoma on intact uterine cervix: Results and prevention;Complications des traitements des cancers invasifs du col uterin sur uterus intact. Resultats et prevention

Cancer/Radiotherapie

Volumn 4, Issue 2, 2000, Pages 147-158

  Barillot, I ^a   Maingon, P ^a   Truc, G ^a   Horiot, J C ^a  

^a CENTRE GEORGES FRANÇOIS LECLERC   (France)

Author keywords

Brachytherapy; Complication; Radiation therapy; Surgery; Uterine cervix carcinoma

Indexed keywords

BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; HUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING; UTERINE CERVIX CARCINOMA;

EID: 0034163316     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(00)88899-X     Document Type: Article

References (82)

1. Barillot I, Horiot JC, Maingon P, Bone-Lepinoy MC, Vaillant D, Feutray S. Maximum and mean bladder dose defined by ultrasonography. Comparison with the ICRU reference in gynecological brachytherapy. Radiother Oncol 1994 ; 30 : 231-8.
2. Barillot I, Horiot JC, Maingon P, Bone-Lepinoy MC, D'Hombres A. Comte J. Carcinomes du col utérin localement avancés (II distaux, barillet et III) traités par irradiation exclusive : Impact de la planification individuelle des traitements sur les résultats, les séquelles et les complications. Bull Cancer Radiothér 1996 ; 83 : 364-9.
3. Barillot I. Horiot JC. Maingon P, Truc G. D'Hombres A, Chaplain G, Comte J. Decision rules for prevention of complications in cervix carcinomas. In: Livre du Workshop, GEC/ESTRO Meeting; 1998 May; Milano. p. 77-84.
4. Bosze P. Meszaros I. Palfalvi L, Ungar L. Perioperative complications of 116 radical hysterectomies and pelvic node dissections. Eur J Surg Oncol 1993 ; 19 : 605-8.
5. Calais G, Le Floch O, Chauvet B. Reynaud-Bougnoux A, Lansac J, Bougnoux P. Cancers du col utérin stades IB et II proximal. Étude de 213 cas traités par association radiochirurgicale. Gynécologie 1989 : 40 : 498-503.
6. Chassagne D. Cancer du col utérin. Glossaire ou lexique des complications. Bull Cancer 1980 ; 67 : 120-5.
7. Chassagne D, Sismondi P, Horiot JC. Sinistrero G. Bey P. Zola P. et al. A glossary for reporting complications of treatment in gynecological cancers. Radiother Oncol 1993 ; 26 : 195-202.
8. Chatani M, Matayoshi Y, Masaki N, Tesshima T. Inoue T. Long term follow-up results of high-dose rate remote afterloading intracavitary radiation therapy for carcinoma of the uterine cervix. Strahlenther Onkol 1994 ; 170 : 269-76.
9. Chatani M, Matayoshi Y, Masaki N, Narumi Y, Teshima T. Inoue T. Prophylactic irradiation of para-aortic lymph nodes in carcinoma of uterine cervix. A prospective randomized study. Strahlenther Onkol 1995 ; 171 : 655-60.
10. Christie DR, Bull CA, Gebski V, Langlands AO, Concurrent 5- fluorouracil, mitomycin C and irradiation in locally advanced cervix cancer. Radiother Oncol 1995 ; 37 : 181-9.
11. Clark BG, Souhami L. Roman TN, Chappell R, Evans MD, Fowler JF. The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1997 : 38 : 989-93.
12. Coltart RS. Nethersell AB, Thomas S, Dixon AK. A CT based dosimetry system for intracavitary therapy in carcinoma of the cervix. Radiother Oncol 1987 ; 10 : 295-305.
13. Crook JM, Esche BA. Chaplain G, Isturiz J, Sentenac I, Horiot JC. Dose-volume analysis and the prevention of radiation sequelae in cervical cancer. Radiother Oncol 1987 ; 8 : 321-32.
14. Daly NJ. Izar F, Bachaud JM, Delannes M. The incidence of severe chronic ileitis after abdominal and/or pelvic external irradiation with high energy photon beams. Radiother Oncol 1989 ; 14 : 287- 95.
15. Eifel PJ. High dose rate brachytherapy for carcinoma of the cervix: High tech or high risk? Int J Radiat Oncol Biol Phys 1992 ; 24 : 383- 6.
16. Eifel PJ, Levenback C. Wharton JT, Oswald MJ. Time course and incidence of late complications in patients treated with radiation therapy for FIGO lb carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1995 ; 32 : 1289-300.
17. Esche BA, Crook JM, Isturiz J, Horiot JC. Reference volume, milligram-hours and external irradiation for the Fletcher applicator. Radiother Oncol 1987 ; 9 : 255-61.
18. Esche BA, Crook JM, Horiot JC, Dosimetric methods in the optimization of radiotherapy for carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1987 ; 13 : 1183-92.
19. Fine BA, Hempling RE. Piver MS. Baker TR, McAuley M, Driscoll D. Severe radiation morbidity in carcinoma of the cervix: Impact of pretherapy surgical staging and previous surgery, Int J Radiat Oncol Biol Phys 1995 ; 31 : 717-23.
20. Frigerio L, Busci L, Rabaiotti E. Mariani A. Adjunctive radiotherapy after radical hysterectomy in high risk early stage cervical carcinoma. Assessment of morbidity and recurrences. Eur J Gynaecol Oncol 1994 ; 15 : 132-7.
21. Fu KK, Phillips TL, High-dose-rate versus low-dose-rate intracavitary brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1990 ; 19 : 791-6.
22. Gerbaulet A. Kunkler IH. Kerr GR, Haie C, Michem G, Prade M, et al. Combined radiotherapy and surgery: Local control and complications in early carcinoma of the uterine cervix - The Villejuif experience, 1975-1984. Radiother Oncol 1992 ; 23 : 66-73.
23. Gerstner N. Wachter S. Knocke TH, Fellner C, Wambersie A. Pötter R. The benefit of Beam's eye view based 3D treatment planning for cervical cancer. Radiother Oncol 1999 ; 51 : 71-8.
24. Grigsby PW, Lu JD, Mutch DG, Kim RY, Eifel PJ. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aotic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92- 10. Int J Radiat Oncol Biol Phys 1998 ; 41 : 817-22.
25. Haie C. Pejovic MH, Gerbaulet A. Horiot JC, Pourquier H, Delouche J. et al. Is prophylactic para-aortic irradiation worthwhile in the treatment of advanced cervical carcinoma? Results of a controlled clinical trial of the EORTC Radiotherapy Group. Radiother Oncol 1988 ; 11 : 101-12.
26. Haie-Meder C, Kramar A, Lambin P, Lancar R. Scalliet P. Bouzy J, et al. Analysis of complications in a prospective randomized trial comparing two brachytherapy low dose rates in cervical carcinoma, Int J Radiat Oncol Biol Phys 1994 : 29 : 953-60.
27. Horiot J. Fric D. Barillot I. Pigneux J. Schraub S. Pourquier H, et al. Carcinoma of the cervix treated with radiotherapy alone: Results and prevention of complications. In: Mould RF, Battermann JJ, Martinez AA. Speiser BL. eds. Brachytherapy from Radium to Optimization. Acta Oncol 1996 ; 35 : 99-107.
28. Kapp KS, Stuecklschweiger GF. Kapp DS. Poschauko J. Pickel H, Hackl AG. Carcinoma of the cervix: Analysis of complications after proimary external radiation and Ir-192 HDR brachytherapy. Radiother Oncol 1997 ; 42 : 143-53.
29. Keys HM, Bundy BN, Stehman FB, Muderspach LI. Chafe WE. Suggs III CL, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage lb cervical carcinoma. N Engl J Med 1999 ; 340 : 1154-61.
30. Knocke TH, Prokrajac B. Fellner C. Pötter R. A comparison of CT- supported 3D planning with simulator planning in the pelvic irradiation of primary cervical carcinoma. Strahlenther Onkol 1999 : 175 : 68-73.
31. Knutsen BH, Skretting A. Hellebust TP. Olsen DR. Determination of 3D dose distribution from intracavitary brachytherapy of cervical cancer by MRI of irradiated ferrous sulphate gel. Radiother Oncol 1997 ; 43 : 219-27.
32. Komaki R. Brickner TJ. Hanlon AL, Owen JB, Hanks GE, Long-term results of treatment of cervical carcinoma in the United States in 1973, 1978, and 1983. Patterns of Care Study (PCS). Int J Radiat Oncol Biol Phys 1995 ; 31 : 973-82.
33. Lambin P, Gerbaulet A, Kramar A, Scalliet P, Haie-Meder C. Michel G. et al. A comparison of early effects with two dose rates in brachytherapy of cervix carcinoma in a prospective randomised trial. Fur J Cancel 1994 ; 30A : 312-20.
34. Lancar R, Kramar A, Haie-Meder C, Non-parametric methods for analysing recurrent complications of varying severity. Statistics Medicine 1995 ; 14 : 2701-12.
35. Lanciano RM. Martz K. Montana GS. Hanks GE. Influence of age. Prior abdominal surgery, fraction size, and dose on the complications after radiation therapy for squamous cell cancer of the uterine cervix: A patterns of care study. Cancer 1992 ; 69 : 2124-30.
36. Landoni F, Maneo A, Colombo A, Placa F, Milani R, Perego P, Favini G. et al. Randomised study of radical surgery versus radiotherapy for stage lb. la cervical cancer. Lancet 1997 ; 350 : 535-40.
37. Levrant SG. Fruchter RG. Maiman M. Radical hysterectomy for cervical cancer: Morbidity and survival in relation to weight and age. Gynecol Oncol 1992 ; 45 : 317-22.
38. LENT SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys 1995 ; 31 : 1049-91.
39. Logsdon MD, Eifel PJ, Figo IIIB squamous cell carcinoma of the cervix: An analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy. Int J Radiat Oncol Biol Phys 1999 ; 43 : 763-75.
40. MacLeod C. Bernshaw D. Leung S. Narayan K. Firth I. Accelerated hyperfractionnated radiotherapy for locally advanced cervix cancer. Int J Radiat Oncol Biol Phys 1999 ; 44 : 519-24.
41. Magrina JF, Goodrich MA, Weaver AI. Podratz KC. Modified radical hysterectomy: Morbidity and mortality. Gynecol Oncol 1995 ; 59 : 277-82.
42. Massi G, Salvino L, Susini T. Shauta-Amreich vaginal hysterectomy and Wertheim-Meigs abdominal hysterectomy in the treatment of cervical cancer: A retrospective analysis. Am J Obstet Gynecol 1993 ; 168 : 928-34.
43. Montana GS, Fowler WC. Carcinoma of the cervix: Analysis of bladder and rectal radiation dose and complications. Int J Radiat Oncol Biol Phys 1988 ; 16 : 95-100.
44. Morris M, Eifel PJ, Lu J, Grigsby PW, Levenback C, Stevens RE, et al. Pelvic irradiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high risk cervical cancer. N Engl J Med 1999 ; 340 : 1137-43.
45. Newman G. Increased morbidity following the introduction of remote afterloading, with increased dose rate, for cancer of the cervix. Radiother Oncol 1996 ; 39 : 97-103.
46. Noyes WR, Peters NE, Thomadsen BR, Fowler JF, Butchler DA, Stitt JA, et al. Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 1995 ; 31 : 79-86.
47. Ogino I, Kitamura T, Okamoto N, Yamasita K, Aikawa Y, Okajima H, et al. Late rectal complication following high dose rate inlracavitary brachytherapy in cancer of the cervix. Int J Radiat Oncol Biol Phys 1995 ; 31 : 725-34.
48. Orton CG, Seyedsadr M, Somnay A. Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation. Int J Radiat Oncol Biol Phys 1991 ; 21 : 1425-34.
49. Patel FD, Sharma SC, Negi PS, Ghoshal S, Gupta BD. Low dose rate vs. high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: A clinical trial. Int J Radiat Oncol Biol Phys 1994 ; 28 : 335-41.
50. Pedersen D, Bentzen SM, Overgaard J. Reporting radiotherapeutic complications in patients with uterine cervical cancer. The importance of latency and classification system. Radiother Oncol 1993 ; 28 : 134-41.
51. Pedersen D, Bentzen SM, Overgaard J. Early and late radiotherapeutic morbidity in 442 consecutive patients with locally advanced carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1994 ; 29 : 941-52.
52. Perez CA, Camel HM, Kao MS, Askin F. Randomized study of preoperative radiation and surgery or irradiation alone in the treatment of stage IB and IIA carcinoma of the uterine cervix: Preliminary analysis of failures and complications. Cancer 1980 ; 45 : 2759-68.
53. Perez CA, Grigsby PW, Camel HM, Galakatos AE, Mutch D, Lockett MA. Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of uterine cervix: Update of a nonrandomized comparison. Int J Radiat Oncol Biol Phys 1995 ; 31 : 703-16.
54. Perez CA, Grigsby PW, Lockett MA, Chao KSC, Williamson J. Radiation therapy morbidity in carcinoma of uterine cervix: Dosimetric and clinical correlation. Int J Radiat Oncol Biol Phys 1999 ; 44 : 855-66.
55. Pernot M, Hoffstetter S, Peiffert D, Carolus JM, Guillemin F, Verhaeghe JL, et al. Statistical study of a series of 672 cases of carcinoma of the uterine cervix. Results and complications according to age and modalities of treatment. Bull Cancer 1995 ; 82 : 568-81.
56. Petereit DG, Pearcey R. Litterature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: Is there an optimal fractionation schedule. Int J Radiat Oncol Biol Phys 1999 ; 43 : 359-66.
57. Pignon T, Horiot JC, Bolla M, Van Poppel H, Bartelink H, Roelofsen F, et al. Age is not a limiting factor for radical radiotherapy in pelvic malignancies. Radiother Oncol 1997 ; 42 : 107-20.
58. Potish RA, Dusenbery KE. Enteric morbidity of postoperative pelvic external beam and brachytherapy for uterine cancer. Int J Radiat Oncol Biol Phys 1989 ; 18 : 1005-10.
59. Pourquier H, Dubois JB, Delard R. Radiation therapy of cervical cancer with dosimetric prevention of late pelvic complications. Bull Cancer Radiother 1996 ; 83 : 135-43.
60. Rakovitch E, Fyles AW, Pintilie M, Leung PM. Role of mitomycin C in the development of late bowel toxicity following chemoradiation for locally advanced carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1997 ; 38 : 979-87.
61. Rodrigus P, De Winter K, Leers WH, Kock HC. Late radiotherapeutic morbidity in patients with carcinoma of the uterine cervix: The application of the French-Italian glossary. Radiother Oncol 1996 ; 40 : 153-7.
62. Rodrigus P, De Winter K, Venselaar JLM, Leers WH. Evaluation of late morbidity in patients with carcinoma of the uterine cervix following a dose rate change. Radiother Oncol 1997 ; 42 : 137-41.
63. Roeske JC, Mundt AJ, Halpern H, Sweeney P, Sutton H, Powers C, et al. Late rectal sequelae following definitive radiation therapy for carcinoma of uterine cervix: A dosimetric analysis. Int J Radiat Oncol Biol Phys 1997 ; 37 : 351-8.
64. Rose PG, Bundy BN, Watkins EB, Thigpen JT, Deppe G, Maiman MA, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999 ; 340 : 1144-53.
65. Rotman M, Pajak TF, Choi K, Clery M, Marcial V, Grigsby PW, et al. Prophylactic extended-field irradiation of para-aortic lymph nodes in stages IIB and bulky IB and IIA cervical carcinomas. Ten-year treatment results of RTOG 79-20. JAMA 1995 ; 274 : 387-93.
66. Sarkaria JN, Petereit DG, Stitt JA, Hartman T, Chappell R, Thomadsen BR, et al. A comparison of the efficacy and complications rates of low dose-rate versus high dose rate brachytherapy in the treatment of uterine cervical carcinoma. Int J Radiat Oncol Biol Phys 1994 ; 30 : 75-82.
67. Selke P, Roman TN, Souhami L, Freeman CR, Clark BG, Evans MD, et al. Treatment results of high dose rate brachytherapy in patients with carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1993 ; 27 : 803-9.
68. Sinistrero G, Sismondi P, Rumore A, Zola P. Analysis of the complications of cervix carcinoma treated by radiotherapy using the Franco-Italian Glossary. Radiother Oncol 1993; 26 : 203-11.
69. Sismondi P. Sinistrero G, Zola P, Volpe T, Ferraris R, Castelli JL, et al. Complications of uterine cervix carcinoma treatments: The problem of a uniform classification. Radiother Oncol 1989 ; 14 : 9-17.
70. Shigematsu Y, Nishiyama K, Masaki N. Inoue T, Miyata Y, Ikeda H, et al. Treatment of carcinoma of the uterine cervix by remotely controlled afterloading intracavitary radiotherapy with high dose rate: A comparative study with a low-dose rate system. Int J Radiat Oncol Biol Phys 1983 ; 9 : 351-6.
71. Soisson AP, Soper JT, Clarke-Pearson DL, Berchuck A, Montana G, Creasman WT. Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer. Gynecol Oncol 1990 ; 37 : 390-5.
72. Souhami L, Seymour R, Roman TN, Stanimir GW, Trudeau M, Clark BG, et al. Weekly cisplatin plus external beam radiotherapy and high dose rate brachytherapy in patients with locally advanced carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1993 ; 27 : 871-8.
73. Sundfor K, Trope CG, Kjorstad KE. Radical Radiotherapy Versus Brachytherapy Plus Surgery in Carcinoma of the Cervix 2A and 2B - Long-term Results from a Randomiszed Study 1968-1980.
74. Thomas G, Dembo A, Fyles A, Gadalla T, Beale F, Bean H, Prigle J, Rawlings G. Bush R, Black B. Concurrent chemoradiation in advanced cervical cancer. Gynecol Oncol 1990 ; 38 : 446-51.
75. Thomas G, Dembo A, Ackerman I, Franssen E, Balogh J, Fyles A, et al. A randomized trial of standard versus partially hyperfractionated radiation with or without concurrent 5-fluoroucil in locally advanced cervical cancer. Gynecol Oncol 1998 ; 69 : 137-45.
76. Tseng CJ, Chang CT, Lai CH, Soong YK, Hong JH, Tang SG, et al. A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix. Gynecologic Oncology 1997 ; 66 : 52-8.
77. Van den Bergh F, Meertens H, Moonen L, Van Bunningen B, Blom A. The use of a transverse CT image for the estimation of the dose given to the rectum in intracavitary brachytherapy for carcinoma of the cervix. Radiother Oncol 1998 ; 47 : 85-90.
78. Van Lancker M, Storme G. Prediction of severe late complications in fractionated high dose rate brachytherapy in gynecological applications. Int J Radiat Oncol Biol Phys 1991 ; 20 : 1125-9.
79. Varia MA, Bundy BN, Deppe G, Mannel R, Averette HE, Rose PG, et al. Cervical carcinoma metastatic to para-aortic nodes: Extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: A gynecologic oncology group study. Int J Radiat Oncol Biol Phys 1998 ; 42 : 1015-23.
80. Wang CJ, Leung SW, Chen HC, Sun LM, Fang FM, Changchien CC, et al. High-dose-rate intracavitary brachytherapy (HDR-IC) in treatment of cervical carcinoma: 5-year results and implication of increased low-grade rectal complication on initiation of an HDR-IC fraction scheme. Int J Radiat Oncol Biol Phys 1997 ; 38 : 391-8.
81. Whitney CW, Sause W, Bundy BN, Malfetano JH, Hannigan EV, Fowler WC, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: A Gynecologic Oncology Group and Southwest Oncology Group Study. J Clin Oncol 1999 ; 17 : 1339-48.
82. Wong LC, Choo YC, Choy D. Sham ST. Ma HK. Long-terme follow-up of potentialisation of radiotherapy by cis-platinum in advanced cervical cancer. Gynecologic Oncology 1989 ; 35 : 159- 63.